Najafipour Reza, Momeni Abdol Mabood, Mirmazloomi Yousef, Moghbelinejad Sahar
Genetics Research Center, University of Social Welfare and Rehabilitation Science, Tehran, Iran.
Khatam Pathobiology and Genetics lab, Qazvin, Iran.
Int J Mol Cell Med. 2022;11(3):197-206. doi: 10.22088/IJMCM.BUMS.11.3.197.
In this research, we investigated microRNAs (miRNAs) expression profile in MCF-7 breast cancer cell line which treated with 150 µM vitexin. Profiling of miRNAs expression was performed using TaqMan MiRNA Array. Apoptosis was analyzed by flow cytometry and the expression of some genes involved in "anti-proliferative" signaling pathways were evaluated by western blotting and real time PCR methods. Twenty microRNAs were differentially expressed in vitexin treated cells compared to the control. Among them, let-7- b, c were up regulated while miRNA-17-5p was down regulated with highest score. Also, we detected the expression changes of mentioned miRNAs target genes as well as genes involved in caspase apoptosis pathways. Our results provide the first evidence that vitexin can effect miRNA expression in MCF-7 cells. Also based on our finding, vitexin can be an attractive miRNA mediated chemo preventive and therapeutic agent in breast cancer.
在本研究中,我们调查了用150µM牡荆素处理的MCF-7乳腺癌细胞系中的微小RNA(miRNA)表达谱。使用TaqMan miRNA阵列进行miRNA表达谱分析。通过流式细胞术分析细胞凋亡,并通过蛋白质印迹和实时PCR方法评估参与“抗增殖”信号通路的一些基因的表达。与对照相比,20种微小RNA在牡荆素处理的细胞中差异表达。其中,let-7-b、c上调,而miRNA-17-5p下调且下调幅度最大。此外,我们检测了上述miRNA靶基因以及参与半胱天冬酶凋亡途径的基因的表达变化。我们的结果首次证明牡荆素可影响MCF-7细胞中的miRNA表达。基于我们的发现,牡荆素可能是一种有吸引力的、通过miRNA介导的乳腺癌化学预防和治疗剂。